Etretinate (Tigason, Europe; Tegison, USA) in psoriasis: Advantages of low doses progressively increased-Reference-Cited by-同舟云学术

Etretinate (Tigason, Europe; Tegison, USA) in psoriasis: Advantages of low doses progressively increased

Published:1985-11 Issue:5 Volume:13 Page:830
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Dubertret Louis

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Combined treatment of psoriasis with new aromatic retinoid (“Tigason”) in low dosage and triamcinolone ace-tonide cream topically: A double blind trial;Van Der Rhee;Br J Dermatol,1980

2. Systemic use of a new retinoid with and without local dithranol treatment in generalised psoriasis;Orfanos;Br J Dermatol,1976

3. Augmentation of oral methoxsalen-photochemotherapy with an oral retinoic acid derivative;Fritsch;J Invest Dermatol,1978

4. Methotrexate and etretinate as concurrent therapies in severe psoriasis;Vanderveen;Arch Dermatol,1982

5. Dubertret L, Chastang C, Beylot C, et al: Maintenance treatment of psoriasis by “Tigason”: A double blind randomized clinical trial. Br J Dermatol. (In press.)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acitrétine;Annales de Dermatologie et de Vénéréologie;2011-12

2. Management of Psoriasis;BioDrugs;2000-05

3. Medium dose isotretinoin for the treatment of acne;J EUR ACAD DERMATOL;1998

4. Medium dose isotretinoin for the treatment of acne;Journal of the European Academy of Dermatology and Venereology;1998-09

5. Acitretin and Etretinate;Dermatologic Clinics;1993-01